This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Onconox Aps, Quark Pharmaceuticals, Inc.. Active years: 2011-2017.
Company Filing History:
Years Active: 2011-2017
Title: The Innovative Contributions of Daniele Sblattero
Introduction
Daniele Sblattero is a prominent inventor based in Trieste, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, Sblattero's work focuses on addressing critical medical conditions through innovative solutions.
Latest Patents
Sblattero's latest patents include groundbreaking inventions that target specific proteins for therapeutic use. One of his notable patents is for "Antibodies to β2-glycoprotein I and therapeutic uses thereof." This invention involves human recombinant antibodies or fragments that specifically target β2-glycoprotein I (β2GPI). The pharmaceutical compositions derived from this invention are aimed at treating or preventing thrombus formation and fetal loss in patients affected by antiphospholipid syndrome (APS). Another significant patent is for "Recombinant antibodies against CD55 and CD59 and uses thereof." This invention relates to recombinant antibody molecules and functional fragments that neutralize the complement regulatory proteins CD55 and CD59. These molecules are crucial for controlling complement resistance in cancer, and the patent also covers heterodimeric diabody molecules that target CD55/CD59 and CD20.
Career Highlights
Throughout his career, Daniele Sblattero has worked with several notable companies in the biotechnology sector. He has been associated with Onconox Aps and Quark Pharmaceuticals, Inc., where he has contributed to various innovative projects. His expertise in antibody development has positioned him as a key player in the field.
Collaborations
Sblattero has collaborated with esteemed colleagues, including Francesco Tedesco and Pier Luigi Meroni. These partnerships have further enhanced his research and development efforts, leading to advancements in therapeutic applications.
Conclusion
Daniele Sblattero's contributions to biotechnology through his innovative patents and collaborations highlight his significant role in advancing medical science. His work continues to pave the way for new therapeutic approaches to complex health issues.